Helping manufacturers define the characteristics of their devices and determine the appropriate regulatory qualification and classification.
Similar Posts
Submission and assessment timetables for innovative medicines applications
Guidance on the deadlines for initial and response submissions.
Cancel a medicine’s marketing authorisation or other licence
Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.
Medicines: apply for a parallel import licence
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
Field Safety Notices: 8 to 12 September 2025
List of Field Safety Notices from 8 to 12 September 2025.
Field Safety Notices: 4 to 8 August 2025
List of Field Safety Notices from 4 to 8 August 2025.
MHRA approves adrenaline nasal spray – the first needle-free emergency treatment for anaphylaxis in the UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) nasal spray (EURneffy) to be used for the emergency treatment of serious allergic reactions, known as anaphylaxis.